Effect of HCV infection on THP-1 monocytoid cells

Cell Biochemistry and Function

Volumn 23, Issue 5, 2005, Pages 347-352

  Ponzetto, A ^a   Gennero, L ^a   Cutufia, M ^a   Beltramo, T ^a   Enrietto, M ^a   Pescarmona, P ^a   Pugliese, Agostino ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Disturbed iron metabolism; HCV infection; THP 1 cells

Indexed keywords

FERRITIN; MEMBRANE ANTIGEN; OXYGEN RADICAL; TRANSFERRIN RECEPTOR; VIRUS ANTIGEN; VIRUS RNA;

ARTICLE; CELL MEMBRANE; CELL SHAPE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; GENOME ANALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFECTION SENSITIVITY; INFECTIOUS HEPATITIS; INOCULATION; INTRACELLULAR MEMBRANE; LEUKEMIA CELL LINE; MONOCYTIC LEUKEMIA; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; VIRUS INFECTION;

ANTIGENS, CD; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CYTOPLASM; FERRITINS; HEPACIVIRUS; HUMANS; MONOCYTES; RECEPTORS, TRANSFERRIN; RNA, VIRAL;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 24944454521     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1158     Document Type: Article

References (29)

1. Allain JP. Transfusion risks of yesterday and of today. Transfus Clin Biol 2003; 10: 1-5.
2. Davis GL. Current therapy for chronic hepatitis C. Gastroenterology 2000; 118(2 Suppl.1): S104-S114.
3. Teixeira R, Pastacaldi S, Papatheodoridis GV, Burroughs AK. Recurrent hepatitis C after liver transplantation. J Med Virol 2000; 61: 443-454.
4. Soriano V, Garcia-Samaniego J, Rodriguez-Rosado R, Gonzales J, Pedreira J. Hepatitis C and HIV infection: biological, clinical, and therapeutic implications. J Hepatol 1999; 31(S1): 119-123.
5. Sulkowski MS. Hepatitis C virus infection in HIV-infected patients. Curr Infect Dis Rep 2001; 3: 469-476.
6. Rosenberg PM, Farrell JJ, Abraczinskas DR, Graeme-Cook FM, Dienstag JL, Chung RT. Rapidly progressive fibrosing cholestatic hepatitis-hepatitis C virus-in HIV coinfection. Am J Gastroenterol 2002; 97: 478-483.
7. Caussin-Schwemling C, Schmitt C, Stoll-Keller F. Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro J Med Virol 20001; 65: 14-22.
8. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and machrophages by HIV during the incubation period of AIDS. Nature 1993; 362: 359-362.
9. Giannini E, Mastracci L, Botta F, et al. Liver iron accumulation in chronic hepatitis C patients without HFE mutations: relationships with histological damage, viral load and genotype and alpha-glutathione S-transferase levels. Eur J Gastroenterol Hepatol 2001; 13: 1355-1361.
10. Olynyk JK. Hepatitis C and iron. Keio J Med 1999; 48: 124-131.
11. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26: 171-176.
12. Okamoto H, Tokita H, Sakamoto M, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993; 74: 2385-2390.
13. Iacovacci S, Manzin A, Barca S, et al. Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology 1997; 26: 1328-1337.
14. Stuyver L, Rossau R, Wyseur A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-1102.
15. Burioni R, Plaisant P, Manzin A, et al. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology 1998; 28: 810-814.
16. Burioni R, Bugli F, Mancini N, et al. Non-neutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinabt Fabs. Virology 2001; 288: 29-35.
17. Savarino A, Calosso L, Piragino A, et al. Modulation of surface transferrin receptors in lymphoid cells de novo infected with human immunodeficiency virus type-1. Cell Biochem Funct 1999; 17: 47-55.
18. Sies H (ed.). Oxidative Stress: Oxidants and Antioxidants. Academic Press: London, 1991.
19. Pugliese A, Tone D, Baccino FM, et al. Candida albicans and HIV-1 infection. Cell Biochem Funct 2000; 18: 235-241.
20. Gennero L, Savarino A, Martini C, et al. Correlation between markers of iron metabolism and HIV-1 replication in HIV-seropositive individuals and in HIV-infected cells. Ligand Assay 1997; 2: 184-190.
21. Goutagny N, Fatmi A, De Ledinghen V, et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003; 187: 1951-1958.
22. Galli M. Viruses and cryoglobulinemia. Clin Exp Rheumatol 1995; 13(813): 63-70.
23. Tone D, Gennero L, Baccino FM, et al. Impaired macrophage phagocytosis of apoptotic neutrophils in patients with HIV-1 infection. Clin Diagn Lab Immunol 2002; 9: 983-986.
24. Olynyk JK, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alpha therapy in chronic hepatitis C. Gastroenterology 1995; 108: 1104-1109.
25. Negro F, Samii K, Rubbia-Brandt L, et al. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis. J Med Virol 2000; 60: 21-27.
26. Rigamonti C, Andorno S, Maduli E, et al. Iron, hepatic stellate cells and fibrosis in chronic hepatitis C. Eur J Clin Invest 2002; 32(S1): 28-35.
27. Cotler SY, Eimond MY, Grettch DR, Wilson YY, Lin Broner MP, Kowly VU. Relationship between iron concentration and HCV RNA level in liver tissue. J Clin Gastroenterol 1999; 29: 322-326.
28. Pugliese A, Gennero L, Cutufia M, et al. HCV infective virions can be carried by human platelets. Cell Biochem Funct 2004; 22.
29. Tordjmann T, Soulie A, Guettier C, et al. Perform and granzyme B lytic expression during chronic viral and autoimmune hepatitis. Liver 1988; 18: 391-397.